Zentalis Pharmaceuticals Statistics

Total Valuation

ZNTL has a market cap or net worth of $295.81 million. The enterprise value is -$86.55 million.

Market Cap	295.81M
Enterprise Value	-86.55M

Important Dates

The next estimated earnings date is Monday, November 4, 2024, before market open.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

ZNTL has 71.11 million shares outstanding. The number of shares has increased by 20.58% in one year.

Shares Outstanding	71.11M
Shares Change (YoY)	+20.58%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	82.38%
Float	50.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.27
Forward PS	n/a
PB Ratio	0.77
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.59, with a Debt / Equity ratio of 0.12.

Current Ratio	6.59
Quick Ratio	6.39
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.99% and return on invested capital (ROIC) is -27.67%.

Return on Equity (ROE)	-42.99%
Return on Assets (ROA)	-24.77%
Return on Capital (ROIC)	-27.67%
Revenue Per Employee	$327,097
Profits Per Employee	-$1.57M
Employee Count	124
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, ZNTL has paid $305,000 in taxes.

Income Tax	305,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.50% in the last 52 weeks. The beta is 1.70, so ZNTL's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	-81.50%
50-Day Moving Average	3.56
200-Day Moving Average	10.09
Relative Strength Index (RSI)	64.97
Average Volume (20 Days)	3,297,191

Short Selling Information

The latest short interest is 12.28 million, so 17.27% of the outstanding shares have been sold short.

Short Interest	12.28M
Short Previous Month	11.57M
Short % of Shares Out	17.27%
Short % of Float	24.10%
Short Ratio (days to cover)	15.09

Income Statement

In the last 12 months, ZNTL had revenue of $40.56 million and -$194.65 million in losses. Loss per share was -$2.75.

Revenue	40.56M
Gross Profit	40.56M
Operating Income	-220.55M
Pretax Income	-194.35M
Net Income	-194.65M
EBITDA	-219.22M
EBIT	-220.55M
Loss Per Share	-$2.75

Full Income Statement

Balance Sheet

The company has $426.39 million in cash and $44.03 million in debt, giving a net cash position of $382.36 million or $5.38 per share.

Cash & Cash Equivalents	426.39M
Total Debt	44.03M
Net Cash	382.36M
Net Cash Per Share	$5.38
Equity (Book Value)	382.58M
Book Value Per Share	5.38
Working Capital	372.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$166.38 million and capital expenditures -$485,000, giving a free cash flow of -$166.86 million.

Operating Cash Flow	-166.38M
Capital Expenditures	-485,000
Free Cash Flow	-166.86M
FCF Per Share	-$2.35

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-543.77%
Pretax Margin	-479.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-411.24%

Dividends & Yields

ZNTL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.58%
Shareholder Yield	-20.58%
Earnings Yield	-65.80%
FCF Yield	-56.41%

Dividend Details

Analyst Forecast

The average price target for ZNTL is $10.86, which is 161.06% higher than the current price. The consensus rating is "Buy".

Price Target	$10.86
Price Target Difference	161.06%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.85%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ZNTL has an Altman Z-Score of 3.08 and a Piotroski F-Score of 1.

Altman Z-Score	3.08
Piotroski F-Score	1